NLRP3 and metabolic dysfunction-associated steatotic liver disease: In NAFLD, inflammasomes, particularly NLRP3, exert a substantial impact on the progression of the liver disease, ranging from steatosis to nonalcoholic steatohepatitis (NASH) and subsequently to liver fibrosis, by orchestrating pyroptosis.